StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.42−0.06 (-4.05%)

Close on Nov 17, 2026Market cap $53.14MP/E –Yield –

Tenax Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Tenax Therapeutics's price to book ratio was 0.5× on Nov 11, 2026, against 0.6× a year earlier. Over the last 4 years it ranged from 0.1× to 464.7×, with a median of 0.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×−0.3
2025Dec 31, 20250.7×+0.5
2024Dec 31, 20240.2×−46.2
2023Dec 29, 202346.4×−298.7
2022Apr 29, 2022345.1×+6.6
2017Apr 28, 2017338.6×–

More Tenax Therapeutics figures

See a number that looks wrong?